{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:51:17Z","timestamp":1760885477579},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T00:00:00Z","timestamp":1260316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s12016-009-8189-z","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T06:56:18Z","timestamp":1260255378000},"page":"20-35","source":"Crossref","is-referenced-by-count":19,"title":["Advantages of Multiplex Proteomics in Clinical Immunology"],"prefix":"10.1007","volume":"41","author":[{"given":"Peter","family":"Lea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasi","family":"Mudumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Kahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Fa","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azar A.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,9]]},"reference":[{"key":"8189_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2009.01.019","volume":"8","author":"T Wu","year":"2009","unstructured":"Wu T, Mohan C (2009) Proteomic toolbox for autoimmunity research. Autoimmunity Reviews 8:595\u2013598","journal-title":"Autoimmunity Reviews"},{"key":"8189_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PGPM.S4708","volume":"2","author":"W Hueber","year":"2009","unstructured":"Hueber W, Robinson WH (2009) Genomics and proteomics: applications in autoimmune diseases. Pharmacogenomics Personalized Medicine 2:39\u201348","journal-title":"Pharmacogenomics Personalized Medicine"},{"key":"8189_CR3","unstructured":"(2008) In: Shoenfeld Y, Cervera R, Gershwin ME (eds) Diagnostic criteria in autoimmune diseases, doi: 10.1007\/978-160327-285-8_5 , Humana, Totowa, NJ, U.S.A."},{"key":"8189_CR4","first-page":"251","volume":"10","author":"P Lea","year":"2008","unstructured":"Lea P, Ling M (2008) New molecular assays for cancer diagnosis and targeted therapy. Current Opinion Molecular Therapeutics 10:251\u2013259","journal-title":"Current Opinion Molecular Therapeutics"},{"key":"8189_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12014-009-9028-1","volume":"5","author":"L Cano","year":"2009","unstructured":"Cano L, Arkfeld DG (2009) Targeted synovial fluid proteomics for biomarker discovery in rheumatoid arthritis. Clinical Proteomics 5:75\u2013102","journal-title":"Clinical Proteomics"},{"key":"8189_CR6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971\u2013983","journal-title":"Nat Biotechnol"},{"key":"8189_CR7","doi-asserted-by":"crossref","first-page":"L16","DOI":"10.1152\/ajplung.00044.2008","volume":"295","author":"RE Gerszten","year":"2008","unstructured":"Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, Klee GG, Kullo I, Laguna TA, Roth FP, Sabatine M, Srinivas P, Wang TJ, Ware LB (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol 295:L16\u2013L22","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8189_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1515\/CCLM.2003.065","volume":"41","author":"PG Rhigetti","year":"2003","unstructured":"Rhigetti PG, Castagna A, Antonucci F et al (2003) The proteome: anno Domini 2002. Clin Chem Lab Med 41:425\u2013438","journal-title":"Clin Chem Lab Med"},{"key":"8189_CR9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/rheumatology\/keh694","volume":"44","author":"K Tilleman","year":"2005","unstructured":"Tilleman K, DeForce D, Elewaut D (2005) Rheumatology: a close encounter with proteomics. Rheumatology 44:1217\u2013122","journal-title":"Rheumatology"},{"key":"8189_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/mcp.M300127-MCP200","volume":"3","author":"NL Anderson","year":"2004","unstructured":"Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A (2004) The human plasma proteome: a non-redundant list developed by combination of four separate sources. Mol Cell Proteomics 3:311\u2013326","journal-title":"Mol Cell Proteomics"},{"key":"8189_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pmic.200400900","volume":"5","author":"K Bjorhall","year":"2005","unstructured":"Bjorhall K, Miliotis T, Davidsson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5:307\u2013317","journal-title":"Proteomics"},{"key":"8189_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/pr034086h","volume":"3","author":"NL Anderson","year":"2004","unstructured":"Anderson NL, Anderson NG, Haines LR, Hardi DB, Olafson RW, Pearson TW (2004) Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies. J Proteome Res 3:235\u2013244","journal-title":"J Proteome Res"},{"key":"8189_CR13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1471-1931(02)00201-X","volume":"20","author":"G Elia","year":"2002","unstructured":"Elia G, Silacci M, Scheurer S, Scheuermann J, Neri D (2002) Affinity-capture reagents for protein arrays. Trends Biotechnol 20:S19\u2013S22","journal-title":"Trends Biotechnol"},{"key":"8189_CR14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/pr050088l","volume":"4","author":"J Martosella","year":"2005","unstructured":"Martosella J, Zolotarjova N, Liu H, Nicol G, Boyes BE (2005) Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 4:1522\u20131537","journal-title":"J Proteome Res"},{"key":"8189_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.aca.2005.09.068","volume":"564","author":"VN Morozov","year":"2006","unstructured":"Morozov VN, Morozova TY (2006) Active bead-linked immunoassay on protein microarrays. Anal Chim Acta 564:40\u201352","journal-title":"Anal Chim Acta"},{"key":"8189_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1513\/pats.200703-044BR","volume":"4","author":"SD Sagel","year":"2007","unstructured":"Sagel SD, Chmiel JF, Konstan MW (2007) Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 4:406\u2013417","journal-title":"Proc Am Thorac Soc"},{"key":"8189_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2006.12.023","volume":"362","author":"JR Whiteaker","year":"2007","unstructured":"Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG (2007) Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 362:44\u201354","journal-title":"Anal Biochem"},{"key":"8189_CR18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971\u2013983","journal-title":"Nat Biotechnol"},{"key":"8189_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jchromb.2003.08.034","volume":"797","author":"J Glokler","year":"2003","unstructured":"Glokler J, Angenendt P (2003) Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797:229\u2013240","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"8189_CR20","unstructured":"SQI Diagnostic Systems, www.sqidiagnostics.com"},{"key":"8189_CR21","unstructured":"Bio-Rad Laboratories. Bio-Rad Bio-Plex System and Suspension Array Technology, accessed December 2007"},{"key":"8189_CR22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/429101a","volume":"429","author":"L Melton","year":"2004","unstructured":"Melton L (2004) Protein arrays: proteomics in multiplex. Nature 429:101\u2013107","journal-title":"Nature"},{"key":"8189_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/14789450.2.4.499","volume":"2","author":"B Kersten","year":"2005","unstructured":"Kersten B, Wanker EE, Hoheisel JD, Angenendt P (2005) Multiplex approaches in protein microarray technology. Expert Rev Proteomics 2:499\u2013510","journal-title":"Expert Rev Proteomics"},{"key":"8189_CR24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jim.2005.11.008","volume":"309","author":"T Waterboer","year":"2006","unstructured":"Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200\u2013204","journal-title":"J Immunol Methods"},{"key":"8189_CR25","unstructured":"US Department of Health and Human Services and Food and Drug Administration Center for Devices. Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays, accessed December 2007"},{"key":"8189_CR26","doi-asserted-by":"crossref","unstructured":"Mueller GA, Mueller CA, Dihazi H (2007) Clinical proteomics\u2014on the long way from bench to bedside? Nephrol Dial Transplant, doi: 10.1093\/ndt\/gfl806","DOI":"10.1093\/ndt\/gfl806"},{"key":"8189_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/14789450.3.4.409","volume":"3","author":"AJ Rai","year":"2006","unstructured":"Rai AJ, Vitzthum F (2006) Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Rev Proteomics 3:409\u2013426","journal-title":"Expert Rev Proteomics"},{"key":"8189_CR28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/pr050034b","volume":"4","author":"J Villanueva","year":"2005","unstructured":"Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P (2005) Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 4:1060\u20131072","journal-title":"J Proteome Res"},{"key":"8189_CR29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903\u2013911","journal-title":"Lancet"},{"key":"8189_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/ard.62.3.261","volume":"62","author":"T Palosuo","year":"2003","unstructured":"Palosuo T, Tilvis R, Strandberg T, Aho K (2003) Fiaggrin related antibodies among the aged. Ann Rheum Dis 62:261\u2013263","journal-title":"Ann Rheum Dis"},{"key":"8189_CR31","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I","volume":"44","author":"B Combe","year":"2001","unstructured":"Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J et al (2001) Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 44:1736\u20131743","journal-title":"Arthritis Rheum"},{"key":"8189_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T (2005) Prognostic laboratory markers of radiographic outcome in rheumatoid arthritis. Ann Rheum Dis 64:196\u2013201","journal-title":"Ann Rheum Dis"},{"key":"8189_CR33","doi-asserted-by":"crossref","unstructured":"Szodoray P, Szabo Z, Kapitany A, Gyetvai A, Lakos G, Szanto S, Szues G, Szekanecz Z (2009) Anti citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev [Epub ahead of print]: May 7, in press","DOI":"10.1016\/j.autrev.2009.04.006"},{"key":"8189_CR34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","volume":"4","author":"MA Boekel van","year":"2002","unstructured":"van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arth Res 4:87\u201393","journal-title":"Arth Res"},{"key":"8189_CR35","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G Steiner","year":"2002","unstructured":"Steiner G, Smolen JS (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4:S1\u2013S5","journal-title":"Arthritis Res"},{"key":"8189_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1529-1049(03)00048-5","volume":"4","author":"JF Marcelletti","year":"2003","unstructured":"Marcelletti JF, Nakamura RM (2003) Assessment of serological markers associated with rheumatoid arthritis: diagnostic autoantibodies and conventional disease activity markers. Clin Appl Immunol Rev 4:109\u2013123","journal-title":"Clin Appl Immunol Rev"},{"key":"8189_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJW Zendman","year":"2006","unstructured":"Zendman AJW, van Venrooij WJ, Pruijn GJM (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 45:20\u201325","journal-title":"Rheumatology"},{"key":"8189_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"8189_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677\u2013680","journal-title":"Rheumatology"},{"issue":"6","key":"8189_CR40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47(6):1089\u20131093","journal-title":"Clin Chem"},{"key":"8189_CR41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning HMT, Habibuw MR, Vandenbroucke JP, Dijkmans BAC (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"8189_CR42","first-page":"231","volume":"32","author":"K Raza","year":"2005","unstructured":"Raza K, Breese M, Nightingale P et al (2005) Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32:231\u2013238","journal-title":"J Rheumatol"},{"key":"8189_CR43","unstructured":"O\u2019Connor TET, Morris A, Smith K, Ricks C, Lea P (2009) Automated Quantitative multiplexed microarray platform. IVD Technology 15(9):43\u201349"},{"key":"8189_CR44","unstructured":"Berglin E (2006) Predictors of disease onset and progression in early rheumatoid arthritis. A Clinical, Laboratory and Radiological Study. Umea University Medical Dissertations: ISBN 91-7264-003-0. Dept Public Health and Clinical Medicine, Rheumatology, Umea, Sweden"},{"key":"8189_CR45","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar1851","volume":"8","author":"F Atzeni","year":"2006","unstructured":"Atzeni F, Sarzi-Puttini P, Dell\u2019 Aqua D, de Portu S, Cecchini G, Cruini C, Carabba M, Meroni PL (2006) Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study. Arth Res & Ther 8:R3","journal-title":"Arth Res & Ther"},{"key":"8189_CR46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW (2002) How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis & Rheumatism 46:357\u2013365","journal-title":"Arthritis & Rheumatism"},{"key":"8189_CR47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2009.01.013","volume":"8","author":"X Bossuyt","year":"2009","unstructured":"Bossuyt X (2009) Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 8:543\u2013548","journal-title":"Autoimmun Rev"},{"key":"8189_CR48","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, deJong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism 48:2741\u20132749","journal-title":"Arthritis & Rheumatism"},{"key":"8189_CR49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","volume":"62","author":"J Vencovsky","year":"2003","unstructured":"Vencovsky J, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427\u2013430","journal-title":"Ann Rheum Dis"},{"key":"8189_CR50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1373\/clinchem.2003.023994","volume":"50","author":"Y Feng","year":"2004","unstructured":"Feng Y, Ke X, Ma R, Chen Y, Hu G, Liu F (2004) Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 50:416\u2013422","journal-title":"Clin Chem"},{"key":"8189_CR51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, Foerger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079\u20131084","journal-title":"Ann Rheum Dis"},{"key":"8189_CR52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1373\/clinchem.2004.034728","volume":"51","author":"IEA Hoffman","year":"2005","unstructured":"Hoffman IEA, Peene I, Pottel H, Union A, Hulstaert F, Meheus L, Lebeer K, De Clercq L, Schatteman L, Poriau S, Mielants H, Veys EM, De Keyser F (2005) Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. Clin Chem 51:261\u2013265","journal-title":"Clin Chem"},{"key":"8189_CR53","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.21269","volume":"52","author":"W Hueber","year":"2005","unstructured":"Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, Sonderstup G, Monach P, Drijfhout JW, van Venrooij WJ, Utz PJ, Genovese MC, Robinson WH (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52:2645\u20132655","journal-title":"Arthritis Rheum"},{"key":"8189_CR54","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Roennelid","year":"2005","unstructured":"Roennelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF (2005) Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5\u00a0year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744\u20131749","journal-title":"Ann Rheum Dis"},{"key":"8189_CR55","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2011","volume":"8","author":"BV Cruyssen","year":"2006","unstructured":"Cruyssen BV, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, Sebag M, Deforce D, Vincent C, Elewaut D, Serre G, De Keyser F (2006) Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arth Res & Ther 8:R122","journal-title":"Arth Res & Ther"},{"key":"8189_CR56","first-page":"1","volume":"8","author":"P Maddison","year":"2006","unstructured":"Maddison P, Huey P (2006) Rheumatic diseases. Serological aids to early diagnosis. Top Rev 8:1\u20138","journal-title":"Top Rev"},{"key":"8189_CR57","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","volume":"8","author":"M Pedersen","year":"2006","unstructured":"Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfart J, Frisch M (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arth Res & Ther 8:R133","journal-title":"Arth Res & Ther"},{"key":"8189_CR58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/03009740600958538","volume":"36","author":"C Nikolaisen","year":"2007","unstructured":"Nikolaisen C, Rekvig O, Nossent HC (2007) Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis. Scandinavian J Rheumatol 36:97\u2013100","journal-title":"Scandinavian J Rheumatol"},{"key":"8189_CR59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa G, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797\u2013808","journal-title":"Ann Intern Med"},{"key":"8189_CR60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10067-008-0999-5","volume":"28","author":"LME Anjos Dos","year":"2009","unstructured":"Dos Anjos LME, Pereira IA, d\u2019Orsi E, Seaman AP, Burlingame RF, Morato EF (2009) A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. Clin Rheumatol 28:153\u2013158","journal-title":"Clin Rheumatol"},{"key":"8189_CR61","doi-asserted-by":"crossref","unstructured":"Tedesco A, D\u2019Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P (2009) A new strategy for the early diagnosis of rheumatoid arthritis:A combined approach. Autoimmunity Reviews 233\u2013237","DOI":"10.1016\/j.autrev.2008.07.031"},{"key":"8189_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-007-8014-5","volume":"34","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Gershwin ME (2008) Whither autoimmunity: the lessons of Anti-CCP and B cell depletion. Clin Rev Allergy Immunol 34:1\u20133","journal-title":"Clin Rev Allergy Immunol"},{"key":"8189_CR63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-8981(03)00182-7","volume":"333","author":"AS Wiik","year":"2003","unstructured":"Wiik AS (2003) Appropriateness of autoantibody testing in clinical medicine. Clin Chim Acta 333:177\u2013180","journal-title":"Clin Chim Acta"},{"key":"8189_CR64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.autrev.2007.01.009","volume":"6","author":"D Villalta","year":"2007","unstructured":"Villalta D, Tozzoli R, Tonutti E, Bizzaro N (2007) The laboratory approach to the diagnosis of autoimmune diseases: is it time to change? Autoimmunity Reviews 6:359\u2013365","journal-title":"Autoimmunity Reviews"},{"key":"8189_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14622416.3.4.527","volume":"3","author":"A Talapatra","year":"2002","unstructured":"Talapatra A, Rouse R, Hardiman G (2002) Protein microarrays: challenges and promises. Pharmacogenomics 3:1\u201310","journal-title":"Pharmacogenomics"},{"key":"8189_CR66","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1074\/mcp.I500001-MCP200","volume":"4","author":"NL Anderson","year":"2005","unstructured":"Anderson NL (2005) The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol Cellu Proteomics 4:1441\u20131444","journal-title":"Mol Cellu Proteomics"},{"key":"8189_CR67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/ar900","volume":"5","author":"W Hueber","year":"2003","unstructured":"Hueber W, Lee BJ, Genovese M, van Venrooij W, Steinman L, Putz PJ, Robinson WH (2003) Multiplex autoantibody profiling using \u2018synovial proteome\u2019 microarrays identifies citrulline-modified peptides as major targets of the autoimmune response in rheumatoid arthritis. Arth Res & Ther 5:99","journal-title":"Arth Res & Ther"},{"key":"8189_CR68","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/prca.200780012","volume":"2","author":"H Tjalsma","year":"2008","unstructured":"Tjalsma H, Schaeps RM, Swinkels SW (2008) Immunoproteomics: from biomarker discovery to diagnostic applications. Proteomics Clin Appl 2:167\u2013180","journal-title":"Proteomics Clin Appl"},{"key":"8189_CR69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2008.03797.x","volume":"28","author":"S Rashtak","year":"2008","unstructured":"Rashtak S, Ettore MW, Homburger HA, Murray JA (2008) Combination testing for antibodies in the diagnosis of celiac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 28:805\u2013813","journal-title":"Aliment Pharmacol Ther"},{"key":"8189_CR70","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1373\/clinchem.2007.099812","volume":"54","author":"M Hartman","year":"2008","unstructured":"Hartman M, Schrenk M, Doettinger A, Nagel S, Roeraade J, Joos TO, Templin MF (2008) Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays. Clin Chem 54:956\u2013963","journal-title":"Clin Chem"},{"key":"8189_CR71","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.autrev.2008.07.032","volume":"8","author":"M Plebani","year":"2009","unstructured":"Plebani M, Pittoni M, Celadin M, Bernadi D, Mion MM (2009) Recent advances in diagnostic technologies for autoimmune diseases. Autoimmunity Reviews 8:238\u2013243","journal-title":"Autoimmunity Reviews"},{"key":"8189_CR72","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1373\/clinchem.2008.120717","volume":"55","author":"AA Ellington","year":"2009","unstructured":"Ellington AA, Kullo IJ, Bailey KR, Klee GG (2009) Measurement and quality control issues in multiplex protein assays: a case study. Clinica Chemistry 55:1092\u20131099","journal-title":"Clinica Chemistry"},{"key":"8189_CR73","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1373\/clinchem.2009.126557","volume":"55","author":"LJ Kricka","year":"2009","unstructured":"Kricka LJ, Master SR (2009) Quality control and protein microarrays. Clin Chem 55:1053\u20131055","journal-title":"Clin Chem"},{"key":"8189_CR74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jcis.2006.11.050","volume":"308","author":"A Simon","year":"2007","unstructured":"Simon A, Girard-Egrot A, Sauter F, Pudda C, Picollet D\u2019Hahan N, Blum L, Chatelain F, Fuchs A (2007) Formation and stability of a suspended bio-mimetic lipid bilayer on silicon submicrometer-sized pores. J Colloid Interface Science 308:337","journal-title":"J Colloid Interface Science"},{"key":"8189_CR75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2005.02.002","volume":"357","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Harris EN (2005) Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 357:17\u201333","journal-title":"Clin Chim Acta"},{"key":"8189_CR76","first-page":"591","volume":"26","author":"P Merkel","year":"1999","unstructured":"Merkel P, Chang Y, Pierangeli SS, Harris EN, Polisson RP (1999) Comparisons between the standard anticardiolipin antibody test and a new phospholipids test in patients with connective tissue diseases. J Rheumatol 26:591\u2013596","journal-title":"J Rheumatol"},{"key":"8189_CR77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaut.2007.02.009","volume":"28","author":"T Koike","year":"2007","unstructured":"Koike T, Bohgaki M, Amengual O, Atsumi T (2007) Antiphospholipid antibodies: lessons from the bench. J Autoimmunity 28:129\u2013133","journal-title":"J Autoimmunity"},{"key":"8189_CR78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/00313020701717720","volume":"40","author":"RCW Wong","year":"2008","unstructured":"Wong RCW, Favaloro EJ, Adelstein S, Baumgart K, Bird R, Brighton TA, Empson M, Gillis D, Hendle MJ, Laurent R, Mallon D, Pollock W, Smith S, Steele RH, Wilson RJ (2008) Consensus guidelines on ant-beta 2 glycoprotein I testing and reporting. Pathology 40:58\u201363","journal-title":"Pathology"},{"key":"8189_CR79","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2004-02-0462","volume":"104","author":"P Lieby","year":"2008","unstructured":"Lieby P, Poindron V, Roussi S, Klein C, Knapp A-M, Garaud J-C, Cerutti M, Martin T, Pasquali J-L (2008) Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 104:1711\u20131715","journal-title":"Blood"},{"issue":"Suppl 1","key":"8189_CR80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/ar1050","volume":"6","author":"PJ Charles","year":"2004","unstructured":"Charles PJ (2004) Multiplex analysis of antinuclear antibodies by flow cytometry using FIDIS. Arthritis Res Ther 6(Suppl 1):8","journal-title":"Arthritis Res Ther"},{"key":"8189_CR81","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.clinbiochem.2005.08.004","volume":"38","author":"C Gonzalez","year":"2005","unstructured":"Gonzalez C, Garcia-Berrocal B, Talavan T, Casas ML, Navajo JA, Gonzalez-Buitrago JM (2005) Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem 38:966\u2013972","journal-title":"Clin Biochem"},{"key":"8189_CR82","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/CCLM.2006.137","volume":"44","author":"R Tozzoli","year":"2006","unstructured":"Tozzoli R, Villalta D, Kodermaz G, Bagnasco M, Tonutti E, Bizarro N (2006) Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. Clin Chem Med 44:837\u2013842","journal-title":"Clin Chem Med"},{"key":"8189_CR83","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/CDLI.11.6.1054-1059.2004","volume":"11","author":"TB Martins","year":"2004","unstructured":"Martins TB, Burlingame R, von Muehlen CA, Jaskowski TD, Litwin CM, Hill HR (2004) Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 11:1054\u20131059","journal-title":"Clin Diagn Lab Immunol"},{"key":"8189_CR84","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/CDLI.12.12.1353-1357.2005","volume":"12","author":"SR Binder","year":"2005","unstructured":"Binder SR, Genovese MC, Merrill JT, Morris RI, Metzger AL (2005) Computer-assisted pattern recognition of autoantibody results. Clin Diagn Lab Immunol 12:1353\u20131357","journal-title":"Clin Diagn Lab Immunol"},{"key":"8189_CR85","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","volume":"365","author":"DA Grimes","year":"2005","unstructured":"Grimes DA, Schulz KF (2005) Refining clinical diagnosis with likelihood ratios. Lancet 365:1500\u20131505","journal-title":"Lancet"},{"key":"8189_CR86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.autrev.2008.07.033","volume":"8","author":"R Kaul","year":"2009","unstructured":"Kaul R, Johnson K, Scholz H, Marr G (2009) Performance of the BioPlex\u2122 2200 autoimmune vasculitis kit. Autoimmunity Reviews 8:224\u2013227","journal-title":"Autoimmunity Reviews"},{"key":"8189_CR87","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1749-6632.2009.04641.x","volume":"1173","author":"M Lidar","year":"2009","unstructured":"Lidar M, Lipschitz N, Langevitz P, Barzilai O, Ram M, Porat-Katz B-S, Pagnoux C, Guilpain P, Sinico RA, Radice A, Bizarro N, Damoiseaux J, Tervaert JWC, Martin J, Guillevin L, Bombardieri S, Shoenfeld Y (2009) Infectious serologies and autoantibodies in Wegener\u2019s granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci 1173:649\u2013657","journal-title":"Ann N Y Acad Sci"},{"key":"8189_CR88","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","volume":"60","author":"C Hintzen","year":"2009","unstructured":"Hintzen C, Quaiser S, Pap T, Heinrich PC, Hermanns HM (2009) Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arth Rheum 60:2102\u20132112","journal-title":"Arth Rheum"},{"key":"8189_CR89","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/art.24634","volume":"60","author":"A Midgley","year":"2009","unstructured":"Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arth Rheum 60:2390\u20132401","journal-title":"Arth Rheum"},{"key":"8189_CR90","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.autrev.2009.01.006","volume":"8","author":"M Marta","year":"2009","unstructured":"Marta M, Meier UC, Lobell A (2009) Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun Rev 8:506\u2013509","journal-title":"Autoimmun Rev"},{"key":"8189_CR91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2008.12.003","volume":"32","author":"X Xiao","year":"2009","unstructured":"Xiao X, Ma B, Dong B, Zhao P, Tai N, Chen L, Wong FS, Wen L (2009) Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun 32:85\u201393","journal-title":"J Autoimmun"},{"key":"8189_CR92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.24136","volume":"60","author":"P Enghard","year":"2009","unstructured":"Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G (2009) CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arth Rheum 60:199\u2013206","journal-title":"Arth Rheum"},{"key":"8189_CR93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2009.01.001","volume":"32","author":"Y Kanazawa","year":"2009","unstructured":"Kanazawa Y, Shimada A, Oikawa Y, Okubo Y, Tada A, Imai T, Miyazaki J, Itoh H (2009) Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes. J Autoimmun 32:104\u2013109","journal-title":"J Autoimmun"},{"key":"8189_CR94","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2008.12.004","volume":"32","author":"K Yang","year":"2009","unstructured":"Yang K, Vega JL, Hadzipasic M, Schatzmann Peron JP, Zhu B, Carrier Y, Masli S, Rizzo LV, Weiner HL (2009) Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J Autoimmun 32:94\u2013103","journal-title":"J Autoimmun"},{"key":"8189_CR95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2009.02.013","volume":"32","author":"P Youinou","year":"2009","unstructured":"Youinou P, Jamin C (2009) The weight of interleukin-6 in B cell-related autoimmune disorders. J Autoimmun 32:206\u2013210","journal-title":"J Autoimmun"},{"key":"8189_CR96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2009.02.002","volume":"32","author":"RD Motrich","year":"2009","unstructured":"Motrich RD, van Etten E, Depovere J, Riera CM, Rivero VE, Mathieu C (2009) Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J Autoimmun 32:140\u2013148","journal-title":"J Autoimmun"},{"key":"8189_CR97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2009.02.001","volume":"32","author":"G Adamus","year":"2009","unstructured":"Adamus G, Karren L (2009) Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J Autoimmun 32:133\u2013139","journal-title":"J Autoimmun"},{"key":"8189_CR98","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Goncalves O, Valente J (2009) Behcet\u2019s disease\u2014a contemporary review. J Autoimmun 32:178\u2013188","journal-title":"J Autoimmun"},{"key":"8189_CR99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaut.2009.02.005","volume":"32","author":"P Chretien","year":"2009","unstructured":"Chretien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, Lons T, Hagege H (2009) Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 32:201\u2013205","journal-title":"J Autoimmun"},{"key":"8189_CR100","doi-asserted-by":"crossref","unstructured":"Karosi T, Szekanecz Z, Sziklai I (2009) Otosclerosis: an autoimmune disease? Autoimmun Rev, in press","DOI":"10.1016\/j.autrev.2009.03.009"},{"key":"8189_CR101","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","volume":"8","author":"T Czompoly","year":"2009","unstructured":"Czompoly T, Simon D, Czirjak L, Nemeth P (2009) Anti-topoisomerase I autoantibodies in systemic sclerosis. Autoimmun Rev 8:692\u2013696","journal-title":"Autoimmun Rev"},{"key":"8189_CR102","doi-asserted-by":"crossref","unstructured":"Sa MJ (2009) Acute transverse myelitis: a practical reappraisal. Autoimmun Rev, in press","DOI":"10.1016\/j.autrev.2009.04.005"},{"key":"8189_CR103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","volume":"33","author":"P Invernizzi","year":"2009","unstructured":"Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M (2009) Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 33:12\u201316","journal-title":"J Autoimmun"},{"key":"8189_CR104","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","volume":"61","author":"FJ Lopez-Longo","year":"2009","unstructured":"Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, Gonzalez-Diaz de Rabago E, Sanchez-Ramon S, Rodriguez-Mahou M, Paravisini A, Monteagudo I, Gonzalez CM, Garcia-Castro M, Casas MD, Carreno L (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arth Rheum 61:419\u2013424","journal-title":"Arth Rheum"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8189-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-009-8189-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8189-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T03:54:25Z","timestamp":1590292465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-009-8189-z"}},"subtitle":["The Case of Rheumatoid Arthritis: Novel IgXplex\u2122 Planar Microarray Diagnosis"],"short-title":[],"issued":{"date-parts":[[2009,12,9]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["8189"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8189-z","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,9]]}}}